Brevium
- Frazier VC
- Jan 20
- 1 min read
Deal Snapshot
Company: Brevium, Inc.
Website: https://brevium.com/
Sector / Category: Healthcare SaaS / Patient Reactivation Software / Practice Optimization Software
Headquarters: American Fork, Utah, United States
Investor: Frazier VC
Investment Vehicle: Fund IV
Deal Type: Primary - Series A
Company Overview
Brevium is a healthcare software provider specializing in patient reactivation and engagement systems. Its platform is designed to help medical practices identify and re-engage patients who have fallen out of care, improve appointment scheduling and recall processes, and increase practice revenue by filling open appointment slots. Brevium’s automated solution integrates with practice management systems and uses data-driven algorithms to reconnect inactive patients through multiple channels — phone, text, email, and more — improving patient outcomes and practice profitability.
Brevium works with a wide range of medical specialties including ophthalmology, allergy, behavioral health, ENT, gastroenterology, optometry, pain management, urology, OB/GYN, dermatology, cardiology, and primary care practices.
Investment Summary
Frazier VC has provided capital to Brevium across multiple rounds, demonstrating continued confidence in the company’s growth and mission. Fund IV completed three investments in Brevium between 2023 and 2025.
Why We Invested
Frazier VC invested in Brevium because the company is positioned for strong growth with a scalable SaaS platform in a durable healthcare market. Brevium’s focus on patient reactivation and retention delivers clear ROI for medical practices and differentiates the company from basic reminder and scheduling tools. The platform’s integration into practice workflows creates meaningful barriers to entry and high switching costs. We also believe Brevium’s leadership team has the experience and execution strength to scale the business over time.
